BiotechTube
Home/Starget Pharma/Sigal Kalmanson Cusnir
SK

Sigal Kalmanson Cusnir

CEO

Starget Pharma

Therapeutic Areas

Oncology

Starget Pharma Pipeline

DrugIndicationPhase
DOTA‑PTR‑58SSTR3‑positive solid tumors (soft‑tissue, neuroendocrine, skin, liver)Preclinical

Leadership Team at Starget Pharma

MA
Michel Afargan, Ph.D.
Head of Drug Development
View full Starget Pharma profile